Navigation Links
Cannabis can Help to Treat Allergies, Autoimmune Disorders

Latest research suggests that cannabis, also known as marijuana or ganja, can help in the treatment of allergies and autoimmune disorders that occur when body tissues are attacked by its own immune system.

Researchers led by Andreas Zimmer, at the University of Bonn, used tetrahydrocannabinol (THC), the active ingredient in the cannabis plant to treat mice and found that it reduced skin allergies.

However, the researchers warned that people who currently suffer from autoimmune diseases should not try to self-medicate marijuana because of its side effects, reported the online edition of the New Scientist.

The human body contains endocannabinoids, which are marijuana like substances. They are produced in the body naturally.

The researchers created a group of mice that lack the receptor for endocannabinoids and noticed that the mice soon developed a severe skin allergy to the nickel in the metal tags the researchers had fastened to their ears.

Zimmer set up a series of experiments to test the anti-allergy effect of natural and synthetic THC compounds and found that they reduced skin irritation by half.

The researches also said they found that mouse skin cells exposed to synthetic THC release fewer cytokines, chemicals that attract immune cells to the site of infection or irritation.


'"/>




Page: 1

Related medicine news :

1. Cannabis for pain
2. Cannabis to be tested to help patients with respiratory diseases
3. Cannabis exerts protective effect against cancer
4. Relief For British MS Patients: Cannabis-Based Oral Spray
5. Alcohol And Drug Abuse (Cannabis) Leading Causes For Road Traffic Accidents
6. Government May Downgrade Cannabis
7. Can Cannabis Cause Madness?
8. Campaigners Say No To Cannabis Reclassification
9. No Increased Schizophrenia Risk With Use Of Cannabis
10. Tackling of Cannabis Addiction
11. Australia Set To Implement A national Strategy Tackle Cannabis Abuse
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: